Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine

Thumbnail
View/Open
Date
2012
Author
Erguven, M.
Bilir, A.
Yazihan, N.
Korkmaz, S.
Aktas, E.
Ovalioglu, C.
Dundar, T.
Seyithanoglu, H.
Metadata
Show full item record
Abstract
The purpose of the present study was to overcome resistance to imatinib (IM) by combining it with roscovitine (ROSC) and to investigate whether or not midkine (MK) had an effect on this combination in the treatment of glioblastoma (GBL). Human T98 GBL cel
URI
https://doi.org/10.3892/ol.2011.434
http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1559
Collections